U
Ulrich T. Hopt
Researcher at University of Freiburg
Publications - 349
Citations - 11279
Ulrich T. Hopt is an academic researcher from University of Freiburg. The author has contributed to research in topics: Pancreatitis & Pancreas. The author has an hindex of 50, co-authored 347 publications receiving 10112 citations. Previous affiliations of Ulrich T. Hopt include University Medical Center Freiburg.
Papers
More filters
Journal ArticleDOI
Arguments for an individualized closure of the pancreatic remnant after distal pancreatic resection
TL;DR: While hand suture closure was a risk factor in the low-risk pancreas subgroup, high BMI further increased the fistula rate for a high-risk pancakes, and a risk-adapted and indication- Adapted choice of the closure method for the pancreatic remnant is proposed to reduce pancreatic Fistula rate.
Journal ArticleDOI
The pathobiological impact of cigarette smoke on pancreatic cancer development (review).
TL;DR: A multifactorial model of tobacco smoke-induced pancreatic carcinogenesis is outlined, showing that pancreatic cancer progenitor cells do not only derive from the ductal lineage, but also from acinar cells, which sheds new light on cigarette smoking-induced acinar cell damage.
Journal ArticleDOI
Ring drape do not protect against surgical site infections in colorectal surgery: a randomised controlled study
TL;DR: Plastic ring drape for wound protection does not guard against SSIs in colorectal surgery, as compared with standard cloth towels.
Journal ArticleDOI
Protective role of heme oxygenase-1 in pancreatic microcirculatory dysfunction after ischemia/reperfusion in rats.
Ernst von Dobschuetz,Rene Schmidt,M. Scholtes,Oliver Thomusch,Christian I. Schwer,Klaus Geiger,Ulrich T. Hopt,Benedikt H. J. Pannen +7 more
TL;DR: Heme oxygenase 1 plays a beneficial role in pancreatic microcirculatory derangements after I/R, which could be of therapeutic relevance after pancreas transplantation and other forms of postischemic pancreatitis.
Journal ArticleDOI
Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after partial PANCreatoduodenectomy (RECOPANC): study protocol of a randomized controlled trial UTN U1111-1117-9588
Ulrich F. Wellner,Sabine Brett,Thomas Bruckner,Ronald Limprecht,Inga Rossion,Christoph M. Seiler,Olivia Sick,I. Wegener,Ulrich T. Hopt,Tobias Keck +9 more
TL;DR: RECOPANC is a prospective, randomized, controlled multicenter trial with two treatment arms, pancreatogastrostomy versus pancreatojejunostomy, hypothesis being that postoperative pancreatic fistula rate is lower after Pancreatoduodenectomy when compared to pancreatoenterostomy.